Bromocriptine-KV

Prevention of lactation for medical reasons. Prevention or suppression of physiological lactation in the postpartum period only for medical reasons (such as intrapartum fetal death, neonatal death, maternal HIV infection).

Bromocriptine is not recommended for routine lactation suppression or for the relief of symptoms of postpartum pain and breast engorgement in cases where non-drug methods (delicate breast support, cold compresses) and/or non-narcotic painkillers are effective.

Hyperprolactinaemia

Treatment of hyperprolactinemia in patients with hypogonadism and/or galactorrhea.

Menstrual disorders, female infertility

Treatment of female infertility with normal basal gonadotropin levels and hyperprolactinemia (absolute or relative).

Prolactinomas

In several specialized departments, patients with prolactin-secreting adenomas have been successfully treated with bromocriptine. Bromocriptine can be considered as a first-line treatment for patients with macroadenomas and as an alternative to surgery (transsphenoidal hypophysectomy) in patients with microadenomas.

Acromegaly

Bromocriptine is used in some specialized departments as an adjunct to surgery and/or radiotherapy to reduce the level of growth hormone in the systemic bloodstream in the treatment of patients with acromegaly.

Parkinson’s disease

In the treatment of idiopathic Parkinson’s disease, bromocriptine is used as monotherapy or in combination with levodopa in patients who have not been previously treated and in patients with on-off phenomenon.

Bromocriptine has been used with occasional efficacy in patients who do not respond to or cannot tolerate levodopa treatment, as well as in patients whose response to levodopa is decreasing. Additionally, there is insufficient evidence for the efficacy of bromocriptine in the treatment of benign breast disease and premenstrual symptoms. Therefore, the use of bromocriptine in patients with these conditions is not recommended.